The Actemra (Tocilizumab) market is witnessing steady growth over the forecast period, supported by increasing autoimmune disease burden, expansion into new inflammatory indications.
Read More
The Accretropin market is witnessing steady growth over the forecast period, supported by growing pediatric endocrine disorder prevalence, increasing adult growth hormone deficiency diagnosis.
Read More
The Acam2000 market is witnessing steady growth over the forecast period, supported by renewed mpox outbreaks, increased biodefense funding.
Read More
The Abrysvo Or Arexvy market is witnessing steady growth over the forecast period, supported by expanding elderly demographics, rising rsv hospitalization rates.
Read More
The Abevmy market is witnessing steady growth over the forecast period, supported by expanding biosimilar penetration in oncology, growing demand for affordable cancer therapies.
Read More
The Abecma market is witnessing steady growth over the forecast period, supported by expansion into earlier treatment lines, improvements in manufacturing efficiency.
Read More
The Blincyto market is witnessing steady growth over the forecast period, supported by growth in precision medicine adoption, increasing approvals for immunotherapies.
Read More
The Bivigam market is witnessing steady growth over the forecast period, supported by rising prevalence of immune disorders, expansion of neurological ivig applications.
Read More
The Biothrax market is witnessing steady growth over the forecast period, supported by increased homeland security investments, rising global biodefense collaborations.
Read More
The Biorab market is witnessing steady growth over the forecast period, supported by expansion of rabies elimination goals, rising public health funding.
Read More